ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
1,654
Screening encounters
1,756
Diagnostic referrals
332
Outstanding pathways
151

Screening pathway

  1. Screening1,756Encounters
  2. Positive finding584Documented findings
  3. Referral332Diagnostic referrals
  4. Follow-up361Diagnostic visits
  5. Outcome181Resolved pathways

Stage totals use different units. Pending pathways: 151. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 3669 · EXP-3669Synthetic · Site C

Full participant history through 2025-10-28, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA technically uninterpretable · Inadequate
  3. · Repeat plan · VIA · Inadequate result · Scheduled for 2025-08-13
  4. · Screening · VIA · Repeat · Inadequate result
  5. · Screening result · VIA · VIA positive · Adequate
  6. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-02-21
  7. · Diagnostic referral · EXP-3669-T-R
  8. · Contact attempt · Reached
  9. · Diagnostic booking · Initial booking
  10. · Diagnostic visit · Attended
  11. · Diagnosis · Colposcopy · Biopsy collected
  12. · Diagnosis · Histopathology · No high-grade lesion identified
  13. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-10-23
  14. · Follow-up disposition · Resolved · EXP-3669-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Screened participants

1654 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-3492 · Expanded synthetic participant 3492Site D — Community Engagement Programme
EXP-3494 · Expanded synthetic participant 3494Site D — Community Engagement Programme
EXP-3495 · Expanded synthetic participant 3495Site D — Community Engagement Programme
EXP-3496 · Expanded synthetic participant 3496Site E — Resource-Constrained Navigation Programme
EXP-3498 · Expanded synthetic participant 3498Site A — Urban Referral Hub
EXP-3500 · Expanded synthetic participant 3500Site C — Rural Outreach Programme
EXP-3501 · Expanded synthetic participant 3501Site A — Urban Referral Hub
EXP-3502 · Expanded synthetic participant 3502Site C — Rural Outreach Programme
EXP-3503 · Expanded synthetic participant 3503Site A — Urban Referral Hub
EXP-3506 · Expanded synthetic participant 3506Site E — Resource-Constrained Navigation Programme
EXP-3508 · Expanded synthetic participant 3508Site A — Urban Referral Hub
EXP-3512 · Expanded synthetic participant 3512Site E — Resource-Constrained Navigation Programme
EXP-3513 · Expanded synthetic participant 3513Site E — Resource-Constrained Navigation Programme
EXP-3514 · Expanded synthetic participant 3514Site C — Rural Outreach Programme
EXP-3515 · Expanded synthetic participant 3515Site A — Urban Referral Hub
EXP-3519 · Expanded synthetic participant 3519Site B — Peri-Urban Access Programme
EXP-3520 · Expanded synthetic participant 3520Site C — Rural Outreach Programme
EXP-3522 · Expanded synthetic participant 3522Site D — Community Engagement Programme
EXP-3531 · Expanded synthetic participant 3531Site B — Peri-Urban Access Programme
EXP-3534 · Expanded synthetic participant 3534Site B — Peri-Urban Access Programme
EXP-3535 · Expanded synthetic participant 3535Site B — Peri-Urban Access Programme
EXP-3537 · Expanded synthetic participant 3537Site E — Resource-Constrained Navigation Programme
EXP-3540 · Expanded synthetic participant 3540Site B — Peri-Urban Access Programme
EXP-3542 · Expanded synthetic participant 3542Site D — Community Engagement Programme
EXP-3544 · Expanded synthetic participant 3544Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
740
HPV DNA
767
Cytology
249

Navigation activity

Barrier documented
279
Contact attempt
483
Navigation intervention
115
Diagnostic booking
404
Diagnostic visit
361

Documented barriers

Contact difficulty
87
Transport difficulty
94
Appointment coordination
98

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.